Warfarin
What's New
Last Posted: Mar 04, 2021
- Clinical Utility of Pharmacogenomic Data Collected by a Health-System Biobank to Predict and Prevent Adverse Drug Events.
Shah Sonam N et al. Drug safety 2021 - Insight on the Genetics of Atrial Fibrillation in Puerto Rican Hispanics.
Gonzalez-Cordero Ariel F et al. Stroke research and treatment 2021 20218819896 - Evaluating warfarin dosing models on multiple datasets with a novel software framework and evolutionary optimisation.
Truda Gianluca et al. Journal of biomedical informatics 2020 Nov 103634 - Differences in predicted warfarin dosing requirements between Hmong and East Asians using genotype-based dosing algorithms.
Sun Boguang et al. Pharmacotherapy 2020 Nov - Pharmacogenomics for Primary Care: An Overview.
Rollinson Victoria et al. Genes 2020 Nov 11(11) - Warfarin dosing algorithms: a systematic review.
Asiimwe Innocent G et al. British journal of clinical pharmacology 2020 Oct - A model-based cost-effectiveness analysis of pharmacogenomic panel testing in cardiovascular disease management: preemptive, reactive, or none?
Zhu Ye et al. Genetics in medicine : official journal of the American College of Medical Genetics 2020 Oct - Influence of SH2B3 , MTHFD1L , GGCX , and ITGB3 Gene Polymorphisms on theVariability on Warfarin Dosage Requirements and Susceptibility to CVD in the Jordanian Population.
Al-Eitan Laith N et al. Journal of personalized medicine 2020 Sep 10(3) - Description of Pharmacogenomic Testing Among Patients Admitted to the Intensive Care Unit After Cardiovascular Surgery.
Peterson Pamela E et al. Journal of intensive care medicine 2020 Jul 885066620946303 - Pharmacogenomics in kidney transplant recipients and potential for integration into practice.
Nguyen Tam T et al. Journal of clinical pharmacy and therapeutics 2020 Jul
More
About PGx PHGKB
PGx PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other materials that address the translation of genomic and other precision health discoveries into improved health care and prevention related to medications....more
Content Summary
- NIH Information (5)
- COVID-19 (3)
- CDC Publications (1)
- Human Genome Epidemiologic Studies (642)
- GWAS Studies (10)
- Human Genomics Translation/Implementation Studies (75)
- Genomic Tests Evidence Synthesis (35)
- Genomic Tests Guidelines (8)
- Tier-Classified Guidelines (8)
- Non-Genomics Precision Health (3)
- Reviews/Commentaries (40)
- Tools/Methods (3)
- Ethical/Legal and Social Issues (ELSI) (3)
Common PGx Related Topics
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Oct 1, 2020
- Page last updated:Apr 26, 2021
- Content source:


